PMID- 17055560 OWN - NLM STAT- MEDLINE DCOM- 20070117 LR - 20220309 IS - 0091-3022 (Print) IS - 1095-6808 (Electronic) IS - 0091-3022 (Linking) VI - 27 IP - 4 DP - 2006 Dec TI - Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS. PG - 415-35 AB - In the CNS, there are widespread and diverse interactions between growth factors and estrogen. Here we examine the interactions of estrogen and brain-derived neurotrophic factor (BDNF), two molecules that have historically been studied separately, despite the fact that they seem to share common targets, effects, and mechanisms of action. The demonstration of an estrogen-sensitive response element on the BDNF gene provided an impetus to explore a direct relationship between estrogen and BDNF, and predicted that the effects of estrogen, at least in part, might be due to the induction of BDNF. This hypothesis is discussed with respect to the hippocampus, where substantial evidence has accumulated in favor of it, but alternate hypotheses are also raised. It is suggested that some of the interactions between estrogen and BDNF, as well as the controversies and implications associated with their respective actions, may be best appreciated in light of the ability of BDNF to induce neuropeptide Y (NPY) synthesis in hippocampal neurons. Taken together, this tri-molecular cascade, estrogen-BDNF-NPY, may be important in understanding the hormonal regulation of hippocampal function. It may also be relevant to other regions of the CNS where estrogen is known to exert profound effects, such as amygdala and hypothalamus; and may provide greater insight into neurological disorders and psychiatric illness, including Alzheimer's disease, depression and epilepsy. FAU - Scharfman, Helen E AU - Scharfman HE AD - Center for Neural Recovery and Rehabilitation Research, Helen Hayes Hospital, West Haverstraw, NY 10093-1195, USA. scharfmanh@helenhayeshosp.org FAU - MacLusky, Neil J AU - MacLusky NJ LA - eng GR - R01 NS037562/NS/NINDS NIH HHS/United States GR - R56 NS037562/NS/NINDS NIH HHS/United States GR - NS 37562/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20061020 PL - United States TA - Front Neuroendocrinol JT - Frontiers in neuroendocrinology JID - 7513292 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Estrogens) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Neuropeptide Y) RN - 0 (Steroids) SB - IM MH - Adult MH - Animals MH - Brain-Derived Neurotrophic Factor/*physiology MH - Central Nervous System/*physiology MH - Estrogens/*physiology MH - Hippocampus/*physiology MH - Humans MH - Intercellular Signaling Peptides and Proteins/*physiology MH - Mental Disorders/physiopathology MH - Nervous System Diseases/physiopathology MH - Neuropeptide Y/physiology MH - Steroids/*physiology PMC - PMC1778460 MID - NIHMS14582 EDAT- 2006/10/24 09:00 MHDA- 2007/01/18 09:00 PMCR- 2008/01/30 CRDT- 2006/10/24 09:00 PHST- 2006/02/27 00:00 [received] PHST- 2006/08/12 00:00 [revised] PHST- 2006/09/01 00:00 [accepted] PHST- 2006/10/24 09:00 [pubmed] PHST- 2007/01/18 09:00 [medline] PHST- 2006/10/24 09:00 [entrez] PHST- 2008/01/30 00:00 [pmc-release] AID - S0091-3022(06)00376-1 [pii] AID - 10.1016/j.yfrne.2006.09.004 [doi] PST - ppublish SO - Front Neuroendocrinol. 2006 Dec;27(4):415-35. doi: 10.1016/j.yfrne.2006.09.004. Epub 2006 Oct 20.